Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dignam

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
British Journal of Pharmacology|March 16, 2021
Animal models of pulmonary hypertension: Getting to the heart of the problemJoshua P Dignam, Tara E Scott, Barbara K Kemp-Harper, et al.
European Heart Journal Open|February 6, 2026
Estriol attenuates visceral adiposity and pulmonary artery smooth muscle cell proliferation via ERα-mediated signallingSmriti Sharma, Joshua P Dignam, Gregor Aitchison, et al.
Pharmacological Research|October 7, 2024
Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burdenVanessa J Lowe, Aisah A Aubdool, Amie J Moyes, et al.
British Journal of Pharmacology|November 30, 2025
Cytochrome P450 1A1 influences obesity-induced pulmonary hypertensionJoshua P Dignam, Smriti Sharma, Gregor Aitchison, et al.
British Journal of Pharmacology|June 16, 2021
Multidrug resistance proteins preferentially regulate natriuretic peptide-driven cGMP signalling in the heart and vasculatureRobert M H Grange, Michael E J Preedy, Aniruthan Renukanthan, et al.
Pharmacological Research|July 24, 2025
Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertensionJoshua P Dignam, Aisah A Aubdool, Vanessa R Lowe, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
British Journal of Pharmacology|March 16, 2021
Animal models of pulmonary hypertension: Getting to the heart of the problemJoshua P Dignam, Tara E Scott, Barbara K Kemp-Harper, et al.
European Heart Journal Open|February 6, 2026
Estriol attenuates visceral adiposity and pulmonary artery smooth muscle cell proliferation via ERα-mediated signallingSmriti Sharma, Joshua P Dignam, Gregor Aitchison, et al.
Pharmacological Research|October 7, 2024
Cardiomyocyte-derived C-type natriuretic peptide diminishes myocardial ischaemic injury by promoting revascularisation and limiting fibrotic burdenVanessa J Lowe, Aisah A Aubdool, Amie J Moyes, et al.
British Journal of Pharmacology|November 30, 2025
Cytochrome P450 1A1 influences obesity-induced pulmonary hypertensionJoshua P Dignam, Smriti Sharma, Gregor Aitchison, et al.
British Journal of Pharmacology|June 16, 2021
Multidrug resistance proteins preferentially regulate natriuretic peptide-driven cGMP signalling in the heart and vasculatureRobert M H Grange, Michael E J Preedy, Aniruthan Renukanthan, et al.
Pharmacological Research|July 24, 2025
Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertensionJoshua P Dignam, Aisah A Aubdool, Vanessa R Lowe, et al.
Pageof 2